Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Generation Bio Co. (NASDAQ:GBIO – Get Rating) – Wedbush issued their Q1 2024 earnings estimates for shares of Generation Bio in a report issued on Thursday, May 11th. Wedbush analyst D. Nierengarten forecasts that the company will earn ($0.44) per share for the quarter. The consensus estimate for Generation Bio’s current full-year earnings is ($2.06) […]
Generation Bio Co. (NASDAQ:GBIO – Get Rating) – Investment analysts at William Blair issued their Q1 2024 earnings per share estimates for shares of Generation Bio in a research report issued on Thursday, May 11th. William Blair analyst M. Minter expects that the company will earn ($0.62) per share for the quarter. William Blair has […]
TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned Researchers Drs. Christine Seidman and Alex Marson... | May 10, 2023
Company entered into strategic collaboration with Moderna to use Generation Bio’s proprietary non-viral genetic medicine delivery system for two liver disease programs and to co-develop novel... | June 16, 2023
Generation Bio Co. (NASDAQ:GBIO – Get Rating) was the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 2,050,000 shares, a decline of 8.1% from the March 31st total of 2,230,000 shares. Currently, 4.8% of the company’s stock are short sold. Based on an average […]